Tests a care strategy to improve cervical cancer screening in Kenya
Tests a care program helping women get cervical cancer screening and treatment.
Plain-language title generated from the registry record
Registry title: Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
Key facts
- Where
- Nairobi, KenyaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 25 and 49 years old?
Source: NCT07050745, who can take part
Where in Kenya
- Kenyatta National HospitalNairobi, KenyaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Kenyatta National Hospital
- Trial code
- NCT07050745
- Record updated
- 12 January 2026
- Original description
This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).Read full original descriptionShow less
Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).
Inclusion: Women ages 25-49 years.
Exclusion: Women already confirmed to have cervical cancer; Pregnant women; Women ≤6 weeks postpartum.